QQ客服 官方微博 反馈留言

	Risk of brain metastasis reduced after erlotinib treatment in advanced pulmonary adenocarcinoma patients with sensitive EGFR mutation
	Liu, Jing; Xing, Ligang; Meng, Xue; Yue, Jinbo; Meng, Xiangjiao; Xie, Peng; Li, Xiaolin; Kong, Li; Yu, Jinming
刊名	ONCOTARGETS AND THERAPY
	2016
卷号	9页码:671-679
关键词	pulmonary adenocarcinoma brain metastasis epidermal growth factor receptor erlotinib match pair analysis
DOI	10.2147/OTT.S100105
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4692430
专题	山东大学
作者单位	Shandong Univ, Shandong Canc Hosp & I
推荐引用方式 GB/T 7714	Liu, Jing,Xing, Ligang,Meng, Xue,et al. Risk of brain metastasis reduced after erlotinib treatment in advanced pulmonary adenocarcinoma patients with sensitive EGFR mutation[J]. ONCOTARGETS AND THERAPY,2016,9:671-679.
APA	Liu, Jing.,Xing, Ligang.,Meng, Xue.,Yue, Jinbo.,Meng, Xiangjiao.,...&Yu, Jinming.(2016).Risk of brain metastasis reduced after erlotinib treatment in advanced pulmonary adenocarcinoma patients with sensitive EGFR mutation.ONCOTARGETS AND THERAPY,9,671-679.
MLA	Liu, Jing,et al."Risk of brain metastasis reduced after erlotinib treatment in advanced pulmonary adenocarcinoma patients with sensitive EGFR mutation".ONCOTARGETS AND THERAPY 9(2016):671-679.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。